These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6223612

  • 1. Some T-cell functions in patients with viral myocarditis. The effect of levamisole.
    Goch JH, Czernicki J, Offierska M.
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):395-404. PubMed ID: 6223612
    [Abstract] [Full Text] [Related]

  • 2. Some T-cell functions in patients with viral myocarditis. The effect of polymorphonuclear leukocyte (PMNL) lysosome factors on T-suppressor cell activity in vitro.
    Czernicki J, Goch JH.
    Arch Immunol Ther Exp (Warsz); 1983; 31(1):51-6. PubMed ID: 6225406
    [Abstract] [Full Text] [Related]

  • 3. [Effect of levamisole on the activity of the blood T-lymphocytes and of factors they produce in patients with laryngeal cancer].
    Volosevich LI, Lukach EV, Krivokhatskaia LD.
    Eksp Onkol; 1988; 10(3):54-7. PubMed ID: 2970382
    [Abstract] [Full Text] [Related]

  • 4. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
    Pozsonyi T, Jakab L, Fehér J, Cseh K.
    Allergol Immunopathol (Madr); 1982; 10(6):435-9. PubMed ID: 6220589
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures of T and B cells by levamisole in vitro and in vivo.
    Hersey P, Ho K, Werkmeister J, Abele U.
    Clin Exp Immunol; 1981 Nov; 46(2):340-9. PubMed ID: 6461457
    [Abstract] [Full Text] [Related]

  • 6. Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations.
    Pozsonyi T, Fehér J, Jakab L.
    Allergol Immunopathol (Madr); 1981 Nov; 9(1):37-44. PubMed ID: 6973266
    [Abstract] [Full Text] [Related]

  • 7. Immunological cellular regulator and effector mechanisms in myocarditis.
    Maisch B, Bülowius U, Schmier K, Klopf D, Koper D, Sibelis T, Kochsiek K.
    Herz; 1985 Feb; 10(1):8-14. PubMed ID: 2858443
    [Abstract] [Full Text] [Related]

  • 8. Effect of thymus factor and levamisole treatment in patients with persistent nephrotic syndrome.
    Czekalski S, Sulima D, Strzelecka G.
    Proc Eur Dial Transplant Assoc; 1983 Feb; 19():800-3. PubMed ID: 6603617
    [Abstract] [Full Text] [Related]

  • 9. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T, Jakab L, Fehér J.
    Allergol Immunopathol (Madr); 1980 Feb; 8(5):553-8. PubMed ID: 6970515
    [Abstract] [Full Text] [Related]

  • 10. [Characteristics of immunoregulatory lymphocyte subpopulations in patients with congestive cardiomyopathy and nonrheumatic myocarditis studied by monoclonal antibodies].
    Kipshidze NN, Chumburidze VB, Dzidziguri LM, Detashidze MN.
    Ter Arkh; 1984 Feb; 56(10):56-8. PubMed ID: 6151750
    [Abstract] [Full Text] [Related]

  • 11. Levamisole and human lymphocyte surface markers.
    Wybran J, Govaerts A.
    Clin Exp Immunol; 1977 Feb; 27(2):319-21. PubMed ID: 321166
    [Abstract] [Full Text] [Related]

  • 12. T- and B-lymphocytes in pemphigus vulgaris. A clinico-immunological follow-up study of fifty patients with pemphigus vulgaris.
    Mashkilleyson N.
    Acta Derm Venereol; 1987 Feb; 67(3):218-24. PubMed ID: 2442934
    [Abstract] [Full Text] [Related]

  • 13. Long-term effect of levamisole on the immune functions in melanoma patients.
    Joensuu H, Nordman E, Toivanen A.
    Strahlenther Onkol; 1986 Dec; 162(12):753-6. PubMed ID: 3492774
    [Abstract] [Full Text] [Related]

  • 14. [Study of peripheral blood T-lymphocytes by the spontaneous and active "rosette" method using levamisole].
    Liapon AO, Lebedev KA, Mashkilleĭson AL.
    Biull Eksp Biol Med; 1980 May; 89(5):630-2. PubMed ID: 6967335
    [Abstract] [Full Text] [Related]

  • 15. [Immune reactivity and in vitro effect of levamisole in a group of patients with malignant melanoma].
    Sansoni P, Rossetti A, Valente G, Butturini U.
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):51-7. PubMed ID: 6982048
    [No Abstract] [Full Text] [Related]

  • 16. [Use of levamisole in treating chronic viral inflammation of the myocardium].
    Goch JH, Niedworok J, Tkaczewski W, Offierska M.
    Kardiol Pol; 1981 Mar; 24(11-12):731-6. PubMed ID: 7043041
    [No Abstract] [Full Text] [Related]

  • 17. In vitro effect of levamisole on E-rosette formation by T-lymphocytes of uremic patients.
    Modai D, Peller S, Cohen N, Shaked U, Kaufman S.
    Isr J Med Sci; 1983 Mar; 19(3):289-91. PubMed ID: 6303981
    [No Abstract] [Full Text] [Related]

  • 18. [Clinico-immunological parallels in non-coronary diseases of the myocardium].
    Fedorov VV, Kovalenko AD, Ivanov VP.
    Sov Med; 1990 Mar; (6):3-7. PubMed ID: 2144366
    [Abstract] [Full Text] [Related]

  • 19. [The influence of levamisole in vitro on lymphocytes from an immunodeficient patient].
    Conti P, Cifone MG, Alesse E, Bruno G, Mantovanelli M, Rossi A.
    Boll Soc Ital Biol Sper; 1980 May 30; 56(10):981-5. PubMed ID: 6969598
    [Abstract] [Full Text] [Related]

  • 20. CD8+ T-lymphocytes infiltrate the myocardium in fulminant herpes virus myocarditis.
    Koga M, Fujiwara M, Ariga S, Isumi H, Tashiro N, Matsubara T, Furukawa S.
    Pediatr Pathol Mol Med; 2001 May 30; 20(3):189-95. PubMed ID: 11486349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.